- Investing Ideas
- Swiss Pharmaceuticals & Biotech Profitable Climbers
Swiss Pharmaceuticals & Biotech Profitable Climbers
Results
3
0 new
3 companies
Kuros Biosciences
Market Cap: CHF 818.4m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 20.74
7D
-3.3%
1Y
-27.4%
SKAN Group
Market Cap: CHF 1.3b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 56.30
7D
-0.9%
1Y
-23.9%
Galderma Group
Market Cap: CHF 40.5b
Operates as a dermatology company worldwide.
GALD
CHF 172.50
7D
-0.2%
1Y
35.5%